Viewing Study NCT05660135


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-05 @ 6:21 PM
Study NCT ID: NCT05660135
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-24
First Post: 2022-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
Sponsor: Daewoong Pharmaceutical Co. LTD.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module